OR-20-0009
implement temporary changes to the Oregon 1915(j) Independent Choices Program related to Oregon’s response to the COVID 19 pandemic during the period of the Presidential and Secretarial emergency declarations (or any renewals thereof).
OR-20-0008
implement temporary changes to the Oregon 1915(k) Independent Choices Program related to Oregon’s response to the COVID 19 pandemic during the period of the Presidential and Secretarial emergency declarations (or any renewals thereof).
PA-20-0004
disproportionate share hospital payment to qualifying trauma facilities
PA-20-0007
Disproportionate Share Payments to Qualifying Hospitals
KY-20-0009
This time-limited state plan amendment responds to the COVID-19 national emergency. The purpose of this amendment is to not applying rate sanctions for the rate quarters of July and October 2020 to the nursing facility per diem rates.
CMS Guidance: Reporting Eligible Identifiers in T-MSIS
The data captured in T-MSIS is valuable for researchers who are building and evaluating innovation models. It provides researchers with historical data on model participants, as well as control data to compare against. As researchers began to use the T-MSIS data, several shortcomings were noted. It can be difficult to link data collected independently of T-MSIS with data residing in T-MSIS for many states. A major factor causing this challenge is that some states do not use a Medicaid beneficiary’s Medicaid Card ID as their MSIS-IDENTIFICATION-NUM in T-MSIS. Beneficiary identifiers in T-MSIS (i.e., the MSIS-IDENTIFICATION-NUMs) are also subject to change.
Collections:
CT-20-0012
Increases the rates for the Long-Acting Reversible Contraceptive devices (LARCs). Adds Healthcare Common Procedure Coding System (HCPCS) code J2350 - Ocrelizumab to the physician office and outpatient fee schedule at $57.42 based on the current approved Medicaid State Plan reimbursement methodology at 100% of the January 2020 Medicare Average Sales Price (ASP) Drug Pricing file for physician-administered drugs, immune globulins, vaccines and toxoids
MN-19-0009
Reinstates the Recovery Audit Contractor (RAC) Program
Section 1135 Waiver Flexibilities - Alaska Coronavirus Disease 2019
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Alaska for multiple section 1135 flexibilities on April 2, 2020. Your initial 1135 request included a request for additional flexibilities we can now approve.
Collections:
AK-20-0004
This time-limited state plan amendment responds to the COVID-19 national emergency. The purpose of this amendment is to allow licensed practitioners within their scope of practice to order & receive reimbursement for laboratory, radiology and home health services, allow laboratory services to be delivered outside an office, or similar facility other than a hospital outpatient department or clinic, when meeting the state’s provider qualifications.